Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #257382 on Avid Bioservices Inc (CDMO)
Couch
03/07/16 7:17 PM
#257383 RE: PPHMownsME #257382
The interim analysis showed that the bavituximab combination group is performing as expected according to the original trial assumptions in terms of overall survival,
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads